Business Charles Schwab to Launch Bitcoin and Ethereum Trading in 2026 Amid Analyst Concerns Charles Schwab plans to start trading Bitcoin and Ethereum by 2026, but analysts warn it could disrupt crypto exchanges. editorial4 December, 2025
Business Vanguard”s Crypto Shift Sparks Bullish Sentiment in Mainstream Finance Vanguard"s entry into crypto ETFs opens doors for millions, signaling a shift in market sentiment. editorial3 December, 2025
Business Uniswap and Revolut Join Forces to Simplify Crypto Purchases Uniswap partners with Revolut to streamline crypto purchases across 28 countries. editorial3 December, 2025
Business 21Shares Confirms Details for Dogecoin ETF Ahead of Launch 21Shares announced management fees and custodians for its upcoming Dogecoin ETF, set to launch soon. editorial3 December, 2025
Business Companies Enhance Crypto Security and Compliance with BitHide Wallet BitHide offers businesses a confidential crypto wallet solution to protect sensitive data while ensuring compliance. editorial3 December, 2025
Business Coinbase Collaborates with U.S. Banks to Explore Stablecoins and Crypto Solutions Coinbase is partnering with U.S. banks to pilot stablecoin and crypto custody initiatives. editorial3 December, 2025
Business Kevin O”Leary Makes Strategic Investment in Bitzero Holdings for AI and Bitcoin Mining Kevin O"Leary backs Bitzero Holdings, focusing on infrastructure for Bitcoin and AI operations. editorial3 December, 2025
Business AMINA Bank Integrates Paxos USDG, Enhances Digital Dollar Offering AMINA Bank has adopted Paxos" USDG stablecoin, joining the Global Dollar Network to boost digital dollar accessibility. editorial3 December, 2025
Business Developers and Investors Focus on Mono Protocol”s Promising Presale ICO Mono Protocol"s presale ICO gains traction for its usability and chain abstraction features. editorial3 December, 2025
Business Bitcoin Rallies to $90K as Investors Eye BlockchainFX Presale for Higher Returns Bitcoin"s rise to $90K has investors exploring BlockchainFX presale for better ROI opportunities. editorial3 December, 2025
Business CME Group Unveils Bitcoin Volatility Index to Enhance Institutional Trading CME Group launches a Bitcoin Volatility Index for institutional traders, tracking 30-day implied volatility. editorial3 December, 2025
Business Taurus and Everstake Team Up for Institutional Staking Solutions Taurus partners with Everstake to enable banks to stake major PoS assets while ensuring compliance and custody control editorial3 December, 2025
Business Ethereum Futures Trading Volume Surpasses Bitcoin on CME for First Time Ethereum futures trading volume has overtaken Bitcoin on the CME, marking a significant shift in institutional interest. editorial2 December, 2025
Business Kraken Expands with Acquisition of Backed Finance to Boost Tokenization Efforts Kraken acquires Backed Finance to enhance its tokenization capabilities and accelerate xStocks" global adoption editorial2 December, 2025
Business Strategy Establishes $1.44 Billion Reserve to Safeguard Bitcoin Holdings Until 2029 Strategy aims to protect Bitcoin assets with a $1.44 billion reserve, ensuring no sales before 2029. editorial2 December, 2025
Business Sonnet Secures Approval for $1 Billion HYPE Fund Merger Sonnet BioTherapeutics" shareholders have approved the merger to create a $1 billion Digital Asset Trust. editorial2 December, 2025
Business Uniswap Partners with Revolut to Simplify Crypto Purchases Uniswap Labs has integrated Revolut, enabling users to buy crypto directly within its platforms. editorial2 December, 2025
Business OpenAI”s App Recommendations Ignite Controversy Among Paying ChatGPT Users Paying customers are frustrated after ChatGPT suggested an unrelated app during a tech discussion. editorial2 December, 2025
Business Grayscale Launches First Spot LINK ETF GLNK on NYSE Arca Grayscale Investments has launched the first-ever spot LINK ETF, GLNK, on NYSE Arca, a pivotal moment for Chainlink. editorial2 December, 2025
Business Janux Therapeutics Stock Plummets 41% Following Disappointing Cancer Drug Data Janux Therapeutics shares fell sharply after revealing disappointing trial results for its prostate cancer treatment. editorial2 December, 2025